News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
45 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (24655)
Month
January (2434)
February (2868)
March (3029)
April (3116)
May (3356)
June (2727)
July (2287)
August (2492)
September (2346)
Day
1 (180)
2 (176)
3 (167)
4 (36)
6 (28)
7 (20)
8 (209)
9 (212)
10 (153)
11 (45)
13 (31)
14 (133)
15 (141)
16 (97)
17 (129)
18 (39)
20 (21)
21 (93)
22 (125)
23 (162)
24 (113)
25 (36)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
Editorial
Mikhail, Davis embody the FDA’s stabilization, Seehafer signals AI revolution is coming
Newly solidified in their roles as the heads of CBER and CDER, Karim Mikhail and Michael Davis have been working for months to right the ship that had begun to capsize under former Commissioner Marty Makary. Meanwhile, Jared Seehafer will become the first-ever deputy commissioner focused on artificial intelligence.
September 11, 2026
·
5 min read
·
Jef Akst
Clinical research
Novartis drags peers down with triple asset stumble
Novartis’ shares fell 13% this week after the report of three separate late-stage asset setbacks. The impact went beyond the Swiss drugmaker, dragging peers down across the market.
September 11, 2026
·
1 min read
·
Annalee Armstrong
C-suite
Novartis’ board faces investor scrutiny after M&A misfires and R&D flops
Back-to-back failures of multiple late-phase trials have raised questions about how Novartis has deployed capital in pursuit of drugs to drive growth through the 2030s.
September 11, 2026
·
5 min read
·
Nick Paul Taylor
Press Releases
Battelle Chooses Ennoia Technologies to Help Advance Characterization of RavenStar™ Open RAN Radio Unit
September 11, 2026
·
3 min read
Press Releases
Phinomics Appoints Mark Ross as Chief Data Engineering Officer, Guido Mathews as Chief Business Officer
September 11, 2026
·
2 min read
Press Releases
Dexcom Appoints Glenn Boehnlein to Board of Directors
September 11, 2026
·
2 min read
Press Releases
Agilent to Participate in J.P. Morgan U.S. All Stars Conference 2026
September 11, 2026
·
1 min read
Press Releases
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - September 10, 2026
September 11, 2026
·
2 min read
Press Releases
Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission
September 11, 2026
·
8 min read
Press Releases
Breakthrough T1D-Convened Paper Outlines First International Consensus Guidance on General Population Screening for Early-Stage Type 1 Diabetes
September 11, 2026
·
4 min read
1 of 5
Next